V3A-82224-73569
2 vaccinations
5 coded responses
20 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 788 / TX
- Registered
- 2021-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-12-28
Registered in v-safe
-
2021-12-28
Dose 1 — Pfizer-BioNTech
- 2021-12-28
-
2021-12-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-30
Survey response — days 1–6 daily, dose 1MedDRA: Back pain, Nasal congestion — Feeling: GoodFree text: Back pain and nasal congestionMedDRA releases: 2024-11 · check-in free text available
- 2021-12-31
-
2022-01-02
Survey response — days 1–6 daily, dose 1MedDRA: Back pain — Feeling: Poor · Muscle or body aches · Be unable to do your normal daily activitiesFree text: Back painMedDRA releases: 2024-11 · check-in free text available
-
2022-01-06
Survey response — day 7, dose 1MedDRA: Sneezing — Feeling: GoodFree text: SneezingMedDRA releases: 2024-11 · check-in free text available
- 2022-01-11
-
2022-01-18
Dose 2 — Pfizer-BioNTech
- 2022-01-18
-
2022-01-19
Survey response — days 1–6 daily, dose 2MedDRA: Back pain — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Severe back painMedDRA releases: 2024-11 · check-in free text available
-
2022-01-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, NauseaAdult check-in
-
2022-01-21
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Sneezing — Feeling: Fair · HeadacheFree text: Sneezing and coughingMedDRA releases: 2024-11 · check-in free text available
- 2022-01-22
- 2022-01-23
- 2022-01-25
- 2022-02-01
- 2022-02-10
- 2022-02-15
- 2022-02-22
- 2022-03-01
- 2022-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-28 | Pfizer-BioNTech | No |
| 2 | 2022-01-18 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 1
Systemic reaction (other): Back pain and nasal congestion
Systemic reaction (other): Back pain
Release 10 — day 7, dose 1
Systemic reaction (other): Sneezing
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Severe back pain
Release 11 — days 1–6 daily, dose 2
Systemic reaction (other): Sneezing and coughing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Back pain | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release